Consortium: Bioph-DTE

Bioph-DTE

Implementation and development of BIOphysical tools for the study, Detection and Treatment of disEases"

Description:

Bioph-DTE meets together research and innovation capacities from the public and private sectors to understand the structure-function relationship of biomolecules in metabolic processes with a health consequence, as well as to assess their use to provide services of interest in health. Bioph-DTE will focus its activity on understanding the functioning of these biomolecules as efficient and sophisticated molecular instruments that use their conformation pathology. Researchers in Bioph-DTE have access to a significant number of infrastructures, which are integrated and will allow a qualitative leap in understanding non-communicable pathologies, from cancer to Parkinson’s, including mitochondriopathies considered rare diseases, cardiovascular diseases, amyotrophic lateral sclerosis and other metabolic disorders, as well as infectious diseases, and drug discovery. Bioph-DTE will focus on the identification and characterization of therapeutic targets by understanding the molecular basis of diseases, and on the development of biophysical and cellular tools for diagnosing, prognosis and evaluating potential drugs. This scientific-technical approach will serve as a germ for a network with leadership capacity to attend calls for research projects. The multiple connection points and complementarity of Bioph-DTE lines will enhance the development of joint projects for the raising of national and regional public and private funds. Nonetheless, the main Bioph-DTE aim will be to serve as the basis for attracting competitive international research and innovation funds, particularly European and with special cross-border attention. Bioph-DTE members regularly and actively collaborate with multiple groups at the international level, particularly Europeans. As a result of these contacts, they participate in various actions financed under the EU (ITN-Program Marie Sklodovswka Curie, ERANET EU, INTERREG POCTEFA or FETOpen), as well as with companies in the Biotechnology sector. In the face of the new EU programmes, Bioph-DTE has identified calls whose objectives include its field of action.

Members:

University

  • Milagros Medina Trullenque (PI; University of Zaragoza)
  • Marta Martínez Júlvez_University of Zaragoza
  • Jesús Ignacio Martínez Martínez_University of Zaragoza
  • José Alberto Carrodeguas Villar_University of Zaragoza
  • Ramón Hurtado Guerrero_University of Zaragoza
  • Ana Isabel Gracia Lostao_University of Zaragoza
  • Patricia Ferreira Neila_University of Zaragoza
  • Inés García Rubio_Centro Universitario de la Defensa/University of Zaragoza
  • Nunilo Cremades Casasín_University of Zaragoza
  • Beatriz Herguedas Francés_University of Zaragoza
  • Javier García Nafría_University of Zaragoza
  • Francisco Corzana López_University of La Rioja
  • Juan Fernández Recio_Instituto de la Vid y el Vino (CSIC/University of La Rioja)
  • Lucía Ramírez Nasto_Public University of Navarra
  • Antonio Gerardo Pisabarro de Lucas_Public University of Navarra
  • María Gumersinda Pérez Garrido_Public University of Navarra
  • Rosa M Soler Tatché_University of Lleida
  • Ana Garcerá Teruel_University of Lleida
  • Ana Auxiliadora García García_University of Zaragoza
  • Víctor Taleb Seral_University of Zaragoza
  • Javier Macías León_University of Zaragoza
  • José Daniel Camino Camino_University of Zaragoza
  • Diego de la Fuente Herreruela_University of Zaragoza
  • Pablo José Gracia González_University of Zaragoza
  • Erandi Lira Navarrete_University of Zaragoza
  • Nerea Novo Huerta_University of Zaragoza
  • Martha Isabel Minjarez Saenz_University of Zaragoza
  • Sergio Boneta Martínez_University of Zaragoza
  • Alba Sansa Zaragoza_University of Lleida
  • Carlos Marcuello Anglés_University of Zaragoza
  • Maria Carmen Pallarés Matute_University of Zaragoza

Other entities:

  • Ivonne Jericó Pascual_Complejo Hospitalario de Navarra. Navarrabiomed
  • Inmaculada Pagola Lorz_Complejo Hospitalario de Navarra. Navarrabiomed
  • Laura Torné Hernandez_Complejo Hospitalario de Navarra. Navarrabiomed
  • Manuel Daniel Diaz-Muñoz_ Institut National de la Santé et de la Recherche Médicale (Inserm), Centre National de la Recherche Scientifique (CNRS) y Université Toulouse III-Paul Sabatier (UPS).
  • Vera Pancaldi_ Institut National de la Santé et de la Recherche Médicale (Inserm), Centre National de la Recherche Scientifique (CNRS) y Université Toulouse III-Paul Sabatier (UPS).
  • Juan Enrique Martínez Oliván_Cerstest Biotec
  • Jessika Valero-González_Cerstest Biotec
  • Rafael Claveria Gimeno_Cerstest Biotec
  • Tomás Aragón Amonarriz_Centro de Investigación Médica Aplicada, University of Navarra
  • Montserrat Arrasate Iragui_Centro de Investigación Médica Aplicada, University of Navarra
  • Laura Larrea Velilla_Centro de Investigación Médica Aplicada, University of Navarra
  • Roberto Ferrero Laborda_Centro de Investigación Médica Aplicada, University of Navarra
  • Rodrigo Vinueza Gabilanes_Centro de Investigación Médica Aplicada, University of Navarra
  • Elías Marlin_Centro de Investigación Médica Aplicada, University of Navarra
  • Didio Ortiz_Centro de Investigación Médica Aplicada, University of Navarra

Empresas: Cerstest Biotec